Q1
STE — Q1 2027 Financial Report Analysis
STERIS grew fiscal Q1 2027 revenue 7.3% to $1.49B and diluted EPS 14% to $2.04, led by service and consumables, while reiterating full-year guidance and cutting its free-cash-flow outlook to fund a new chemistry plant.